Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Stevenson M et al. - Bosentan is likely to be a more cost-effective first-line therapy for patients with PAH FC III in the UK than no active intervention.

Today in Economics of Medicine...keeping you current

"Better Ways to Pay for Health Care", Recommended by National Health Care Quality Coalition
AMN Healthcare, 11/25/09

Stimulating EMR adoption
American Medical News , 11/25/09

Hospital ownership and medical services: Market mix, spillover effects, and nonprofit objectives
Journal of Health Economics, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address